Home phlebotomy is increasingly being considered for patients with cancer to improve access to standard care and investigational treatments by reducing time toxicity, according to researchers.
Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.
Patients more likely to have a PPED were female sex, those with breast cancer, those with stage I-III cancer, and those who lived closer to the cancer center. A new definition of oncology-related ...
HealthDay News — A substantial smoking-attributable burden can be avoided by accelerating the pace of smoking elimination, according to a study published in the October issue of The Lancet Public ...
HealthDay News — Few high-risk individuals have heard of or have discussed lung cancer screening (LCS) with a health care practitioner, according to a research letter published online Oct. 30 in JAMA ...
Evidence-based smoking cessation treatment within six months of a cancer diagnosis maximizes survival benefit, according to a study published online Oct. 31 in ...
The biochemically verified smoking cessation rate at week 24 was about 5% higher in Latino adults using the Decídetexto mobile intervention vs standard care. Use of a mobile smoking cessation ...
The PSA50 response rate was 48% in patients with HRR alterations, and there were no responses in patients without HRR alterations. Olaparib monotherapy may be a treatment option for some patients ...